NEUROCRINE BIOSCIENCES INC Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss
NEUROCRINE BIOSCIENCES INC (NBIX) had Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss of $2.06 million as of 2018-09-30, per its 10-Q filed 2018-11-05.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss · last filed 2018-11-05
- 2018-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $2.06M.
- 2018-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $2.81M.
- 2018-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $3.70M.
- 2017-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss $1.85M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss |
|---|---|
| 2018-09-30 | $2.06M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $2.81M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $3.70M 10-Q · filed 2018-04-30 |
| 2017-12-31 | $1.85M 10-Q · filed 2018-11-05 |
| 2017-09-30 | $537.00K 10-Q · filed 2017-11-01 |
| 2017-06-30 | $714.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $244.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $324.00K 10-K · filed 2018-02-13 |
| 2016-09-30 | $209.00K 10-Q · filed 2016-11-02 |
| 2016-06-30 | $125.00K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $298.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $981.00K 10-K · filed 2017-02-14 |
| 2015-09-30 | $668.00K 10-Q · filed 2015-10-29 |
| 2015-06-30 | $430.00K 10-Q · filed 2015-07-29 |
| 2015-03-31 | $220.00K 10-Q · filed 2015-04-30 |
| 2014-12-31 | $283.00K 10-K · filed 2016-02-11 |
| 2014-09-30 | $228.00K 10-Q · filed 2014-11-04 |
| 2014-06-30 | $149.00K 10-Q · filed 2014-08-06 |
| 2013-12-31 | $15.00K 10-K · filed 2015-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |